Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer Susceptibility

Allinen, 2001, Mutation analysis of the CHK2 gene in families with hereditary breast cancer, Br J Cancer, 85, 209, 10.1054/bjoc.2001.1858 Bartek, 2001, CHK2 kinase: a busy messenger, Nat Rev Mol Cell Biol, 2, 877, 10.1038/35103059 Bell, 1999, Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome, Science, 286, 2528, 10.1126/science.286.5449.2528 Bougeard, 2001, Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome, J Med Genet, 38, 253, 10.1136/jmg.38.4.253 Chase, 1998, The North Cumbria Community Genetics Project, J Med Genet, 35, 413, 10.1136/jmg.35.5.413 Chehab, 2000, Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53, Genes Dev, 14, 278 The CHEK2-Breast Cancer Consortium, 2002, Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations, Nat Genet, 31, 55, 10.1038/ng879 Durocher, 2000, The molecular basis of FHA domain: phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms, Mol Cell, 6, 1169, 10.1016/S1097-2765(00)00114-3 Falck, 2001, The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis, Nature, 410, 842, 10.1038/35071124 Ganguly, 1993, Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments, Proc Natl Acad Sci USA, 90, 10325, 10.1073/pnas.90.21.10325 Hofmann, 2001, Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukaemia, Leuk Res, 25, 333, 10.1016/S0145-2126(00)00130-2 Ingvarsson, 2002, Mutation analysis of the CHK2 gene in breast carcinoma and other cancers, Breast Cancer Res, 4, R4, 10.1186/bcr435 Lee, 2000, hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response, Nature, 404, 201, 10.1038/35004614 Lee, 2001, Destabilisation of CHK2 by a missense mutation associated with Li-Fraumeni syndrome, Cancer Res, 61, 8062 Li, 2002, Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2, Mol Cell, 9, 1045, 10.1016/S1097-2765(02)00527-0 Matsuoka, 1998, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase, Science, 282, 1893, 10.1126/science.282.5395.1893 Matsuoka, 2000, Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro, Proc Natl Acad Sci USA, 97, 10389, 10.1073/pnas.190030497 Petrij-Bosch, 1997, BRCA1 genomic deletions are major founders in Dutch breast cancer patients, Nat Genet, 17, 341, 10.1038/ng1197-341 Reddy, 2002, Analysis of CHK2 in vulval neoplasia, Br J Cancer, 86, 756, 10.1038/sj.bjc.6600131 Sodha, 2002, A robust method for detecting CHK2/RAD53 mutations in genomic DNA, Hum Mutat, 19, 173, 10.1002/humu.10031 Sullivan, 2002, Concomitant inactivation of p53 and Chk2 in breast cancer, Oncogene, 21, 1316, 10.1038/sj.onc.1205207 Vahteristo, 2002, A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer, Am J Hum Genet, 71, 432, 10.1086/341943 Vahteristo, 2001, p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni Syndrome, Cancer Res, 61, 5718 Wu, 2001, Characterization of tumor-associated Chk2 mutations, J Biol Chem, 276, 2971, 10.1074/jbc.M009727200 Xu, 2002, Chk2 activation and phosphorylation-dependent oligomerisation, Mol Cell Biol, 22, 4419, 10.1128/MCB.22.12.4419-4432.2002 Zeng, 1998, Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1, Nature, 395, 507, 10.1038/26766 Zhou, 2000, The DNA damage response: putting checkpoints in perspective, Nature, 408, 349, 10.1038/35042558